Literature DB >> 32365207

Combined treatment of tocilizumab and chloroquine on severe COVID-19: a case report.

Chun-Yang Xu1, Sheng-Dong Lu2, Xun Ye3, Meng-Yi Cao1, Gui-Dong Xu4, Qiang Yu5, Jin-Xian Qian6, Gang Zeng6.   

Abstract

Entities:  

Year:  2020        PMID： 32365207      PMCID： PMC7239091          DOI： 10.1093/qjmed/hcaa153

Source DB:  PubMed          Journal:  QJM        ISSN： 1460-2393


× No keyword cloud information.
  3 in total

Review 1.  Clinical Management of COVID-19: A Review of Pharmacological Treatment Options.

Authors:  Ashli M Heustess; Melissa A Allard; Dorothea K Thompson; Pius S Fasinu
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-28

2.  COVID-19 and community self-prescribing: a dangerous folly.

Authors:  Seamas C Donnelly
Journal:  QJM       Date:  2021-11-05

3.  Insights on the Evidence of Cardiotoxicity of Hydroxychloroquine Prior and During COVID-19 Epidemic.

Authors:  Serena Romani; Alexandre Gérard; Audrey Fresse; Delphine Viard; Élise Van-Obberghen; Joëlle Micallef; Fanny Rocher; Milou-Daniel Drici
Journal:  Clin Transl Sci       Date:  2020-10-23       Impact factor: 4.689
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.